期刊文献+

奥曲肽抑制人胃癌细胞株MKN45的生长

Somatostatin analog octreotide inhibited the growth of human gastric cancer cell MKN45 in vitro
下载PDF
导出
摘要 目的 探讨奥曲肽 (Octreotide,OCT)对人胃癌细胞株MKN45生长的调控作用。方法 采用MTT比色分析法分别测定OCT对生长于无血清培养基及含 1 0 %胎牛血清 (FBS)培养基中MKN45细胞的调控作用。结果 OCT 1 0 -2 、1 0 -3 、1 0 -4 g L对培养于无血清培养基中的MKN45的生长均有抑制作用 ,以 1 0 -3 g L浓度的抑制作用最显著 ,为 1 0 .4% ;而OCT 1 0 -2 、1 0 -3 、1 0 -4 、1 0 -5、1 0 -6g L对生长于含 1 0 %FBS培养基中的MKN45均未显示出抑制作用。结论 OCT可抑制无血清培养基中的MKN45的生长。胎牛血清中可能含有可快速降解OCT的肽酶 ,使得OCT未显示出对生长于含 1 0 %FBS培养基中的MKN45的抑制作用。 Objective To study the effects that the somatostatin analog octreotide (OCT) exerted on the growth of human gastric cancer cell MKN45.?Method MTT colorimetric assay was used to measure the growth of MKN45 cell cultured in RPMI 1640 medium with and without 10% FBS, respectively.?Results 10 -2 ,10 -3 ,10 -4 g/L OCT inhibited the growth of MKN45 cell cultured in serum-free medium and the maximum inhibitory rate was 10.40% by 10 -3 g/L OCT; while OCT 10 -2 ,10 -3 ,10 -4 ,10 -5 ,10 -6 g/L did not exert any inhibitory activity on MKN45 grown in the medium containing 10% FBS.?Conclusions OCT inhibited the growth of human gastric cancer cell MKN45 cultured in serum-free medium. It is possible that there are peptidases in serum, which result in the rapid degradation of OCT.
出处 《徐州医学院学报》 CAS 2002年第4期307-309,共3页 Acta Academiae Medicinae Xuzhou
关键词 生长抑素 MTT比色分析法 奥曲肽 胃癌 MKN45细胞株 gastric neoplasms somatostatin MTT colorimetric assay
  • 相关文献

参考文献14

  • 1[1]Cheung NW, Boyages SC. Somatostatin- 14 and its analog Octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block [J]. Endocrinology, 1995, 136(10): 4174 - 4181.
  • 2[2]Nilsson O, Kolby L, Wangberg B, et al. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octrentide scintigraphy and response to octreotide treatment in patients with carcinoid tumors [J]. Br J Cancer, 1998, 77(4): 632-637.
  • 3[3]Hocker M, Wiedenmann B. Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease [J]. Ital J Gastroenterol Hepatol, 1999, (suppl 2): S139-S142.
  • 4[4]Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone[ J].Science, 1973,179(68): 77-79.
  • 5[5]BauerW, BrinerU, DoepfnerW, et al. SMS201-995: a very potent and selective octopeptide analogue of somatostatin with prolonged action[J]. Life Sci,1982,31(11):1133- 1140.
  • 6[6]Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability [J]. J Immunol Methods, 1986, 89(2) :271-277.
  • 7[7]Plumb JA, Milroy R, Kaye SB. Effects of the pH dependence of 3 -(4,5 - dimetylthiazol- 2- yl) - 2,5 - diphenyl-tetrazolium bromide-formazan absorpti on on chemosensitivity determined by a novel tetrazolium- based assay[J]. Cancer Res, 1989, 49(16): 4435-4440.
  • 8[8]Buscail L, Esteve JP, Saint - Laurent N, et al. Inhibition of cell proliferation by the somatostatin analog RC- 160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms[J]. Proc Natl Acad Sci USA, 1995, 92(5): 1580-1584.
  • 9[9]Bruns C, Weckbecker G, Raulf F, et al. Molecular pharmacology of somatostatin -receptor subtypes[J]. Ann N Y Acad Sci, 1994, 733:138- 146.
  • 10[10]Pelicci G, Pagliacci MC, Lanfrancone L, et al. Inhibitory effect of somatostatin analog octreotide on rat pituitary tumor cell (GH3) proliferation in vitro[J]. J Endocrinol Invest, 1990,13(8): 657-662.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部